Prevalence and Determinants of Long COVID among the COVID-19 Survivors: A Cross-sectional Study from A Rural Area of Maharashtra

Authors

  • Mohini Sopanrao Jogdand Swami Ramanand Tirth Rural Government Medical College, Ambajogai, Maharashtra, India https://orcid.org/0009-0005-2942-7459
  • Meghraj Ranchandra Bhondwe Swami Ramanand Tirth Rural Government Medical College, Ambajogai, Maharashtra, India
  • Keerti Sopanrao Jogdand Chhindwara Institute of Medical Sciences, Chhindwara, Madhya Pradesh, India
  • Pravin Nathuji Yerpude Chhindwara Institute of Medical Sciences, Chhindwara, Madhya Pradesh, India
  • Ganesh Rameshrao Tathe Swami Ramanand Tirth Rural Government Medical College, Ambajogai, Maharashtra, India
  • Shweta Subhashrao Wadiyar Swami Ramanand Tirth Rural Government Medical College, Ambajogai, Maharashtra, India

DOI:

https://doi.org/10.47203/IJCH.2023.v35i02.011

Keywords:

Infant, Female, SARS-CoV-2, Cross-Sectional Studies, Prevalence, COVID-19, Post-Acute COVID-19 Syndrome, Surveys and Questionnaires, Survivors, Hospitalization, Intubation, Intratracheal

Abstract

Background: Most patients infected with the COVID-19 virus may experience long-term effects from COVID-19 infection, known as post-COVID or long COVID conditions. Long COVID may last for weeks, months or years and may limit ones day to day activities and needs health care.

Aim & Objective: To study the prevalence and risk factors of long COVID among the COVID-19 survivors of a rural area of Maharashtra.

Methods and Material: A Community-based cross-sectional study was conducted in adult subjects residing in Chanai village from Maharashtra who have had a history of COVID-19 and have passed more than 3 months since the diagnosis from May 2022 to June 2022. The interview of the study participants was conducted with the help of a pre-designed, semi-structured questionnaire for data collection.

Statistical Analysis: Data was analyzed using Microsoft Excel 2010, Open EPI-Info version 3.01 updated on 2013/04/06. Data was presented in tables, graphical format, frequencies and percentages and the statistical association was shown using the chi- square test.

Results: The majority of participants were males (59%), from 19 to 39 years of age group (57%), having fever as presenting symptom (83%), with mild COVID (13%), and required hospitalization (53%). Long COVID was associated with the elderly age group, male sex (27.1%), severe COVID presentation (88.2%) after 12 weeks, and those required intubation (80%).

Conclusion: The prevalence of long COVID was 17.5%. Determinants associated with long COVID were the elderly age group, male sex, severe COVID presentation and who required intubation.

Downloads

Download data is not yet available.

References

World Health Organization. Update 36 – Long-term effects of COVID-19. Geneva: WHO; 2020.available from https://www. who.int/publications/m/item/update-36-long-term-effects-of- covid-19.

Raj SVA, Jacob A, Ambu V, Wilson T, Renuka R. Post COVID- 19 clinical manifestations and its risk factors among patients in a Northern District in Kerala, India. J Family Med Prim Care. 2022;11(9):5312-19.

Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, et al. Post COVID-19 sequelae: A prospective observational study from Northern India. Drug Discov Ther. 2021;15(5):254- 260.

World Health Organization. The latest on the COVID-19 global situation & long-term sequelae. 2021.Available from: https:// www.who.int/publications/m/item/update-54-clinical_long- term-effects-of-COVID-19.

Tleyjeh IM, Saddik B, Alswaidan N, AlAnazi A, Ramakrishnan RK, Alhazmi D, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up. PLoS ONE. 2021;16(12):1-15.

Baig AM. Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID longhaulers. J Med Virol. 2021; 93(5):2555–6.

Callard F, Perego E. How and why patients made Long COVID. Soc Sci Med. 2021;268:1-5.

Ministry of health and family welfare.National Comprehensive Guidelines for Management of Post-COVID Sequelae. Ava i l able f rom ht t p s: //w w w.moh f w.gov.i n /p d f / prehensiveGuidelinesforManagementofPostCovidSequelae. pdf.

Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA network open. 2021; 4(2):1-4.

Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network— United States. MMWR Morbidity and mortality weekly report. 2020; 69(30):993–8.

Perlis RH, Santillana M, Ognyanova K, et al. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open. 2022;5(10):1-5.

Verma A, Patyal A, Mathur M, Choudhary S, Mathur N. Sociodemographic and clinical characteristics associated with COVID mortality among hospitalized patients in Rajasthan: A retrospective observational study. J Family Med Prim Care. 2021;10(9):3319-24.

Mohan A, Tiwari P, Bhatnagar S, Patel A, Maurya A, Dar L, et al. Clinico-demographic profile and hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020;152:61.

Bhandari S, Singh A, Sharma R, Rankawat G, Banerjee S, Gupta V, et al. Characteristics, Treatment outcomes and role of hydroxychloroquine among 522 COVID-19 hospitalized patients in Jaipur City: An epidemio-clinical study. J Assoc Physicians India.2020;68:13–19.

Arjun MC, Singh AK, Pal D, Das K, G. A, Venkateshan M, et al. Characteristics and predictors of Long COVID among diagnosed cases of COVID-19. PLoS ONE.2022;17(12):1-14.

Global COVID-19 Clinical PlatformCase Report Form (CRF) for Post COVID condition .Post COVID19 CRF).2021. Available from: https://www.who. int/publications/i/ item/ global-COVID-19-clinical-platformcase- report-form-for- post-COVID-conditions-post- COVID-19.

Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictorsof acute and chronic post-COVID syndrome: Asystematic review and metaanalysis. EClinicalMedicine.2021; 36:1–13.

Fatima G, Bhatt D, Idrees J,Khalid B, Mahdi F,Mehdi F.Elucida ting Post-COVID-19 manifestations in India. medRxiv.2021. Available from: https://www.medrxiv.org/ content/10.1101/2021.07.06.21260115v1.

Cabrera AL, Pacheco RL, Bagattini AM, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int JClin Pract. 2021; 75(10):1-16.

Downloads

Published

2023-06-30

How to Cite

1.
Jogdand MS, Bhondwe MR, Jogdand KS, Yerpude PN, Tathe GR, Wadiyar SS. Prevalence and Determinants of Long COVID among the COVID-19 Survivors: A Cross-sectional Study from A Rural Area of Maharashtra. Indian J Community Health [Internet]. 2023 Jun. 30 [cited 2024 Jul. 24];35(2):193-8. Available from: https://www.iapsmupuk.org/journal/index.php/IJCH/article/view/2561

Issue

Section

Original Article